Apple’s current valuation presents both upside potential and notable downside risk. Wedbush analyst Dan Ives recently raised his price target to $350 based on a projected launch of upgraded AI-powered features, a resurgence of iPhone demand and accelerating services revenue. However, at roughly 28 times next year’s earnings expectations, Apple trades toward the higher end of its historical multiple range, suggesting that any earnings miss or macroeconomic shock could trigger pronounced share weakness.

During the most recent holiday quarter, Apple reclaimed the top spot in China’s smartphone market, driven by a sharp rebound in shipments of its latest handset. Despite a global memory-chip shortage that dragged on competitors, Apple’s supply-chain resilience and channel inventory management enabled a year-over-year shipment increase of over 20% in Greater China, bolstering its share above 23% in the region.

Apple has inked a multiyear agreement to integrate Google’s Gemini large-language model into its next Siri upgrade, laying the groundwork for personalized on-device AI across its installed base of 2.4 billion active iOS devices and 1.5 billion active handsets. This partnership not only accelerates Apple’s AI roadmap but also positions the company to monetize new subscription services and edge-computing features expected to contribute up to 15% of total services revenue by fiscal 2027.

Institutional activity in Apple shares has been mixed over recent quarters. Berkshire Hathaway sold approximately $4 billion of its position in the first quarter of 2025, while Global Financial Private Client LLC trimmed its stake by 22.5%, reducing holdings to 51,000 shares worth about $13 million. Generali Asset Management also pared its position by 0.9% to 615,558 shares valued at $156.7 million. Insider Chris Kondo sold 3,752 shares, lowering personal ownership by roughly 20%, signaling divergent views on near-term upside among institutional and corporate insiders.